Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Charles River Laboratories International, Inc.

< Previous 1 2 3 4 Next >
Charles River Laboratories Announces Third-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Expands Contract Vivarium Space on West Coast
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Second-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces First-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Acquires Explora BioLabs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Wind Contract with Repsol for European Operations
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Expands Strategic Partnership With SAMDI Tech
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Participate in Upcoming Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Third-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.